Recombinant adeno-associated viral vector production and purification

Area of Science:

• Molecular Biology
• Gene Therapy
• Virology

Background:

• Recombinant adeno-associated virus (AAV) vectors are crucial for investigating muscle development and disease.
• AAV facilitates targeted gene expression modulation (up-regulation, down-regulation, modification) in specific muscles or throughout the body.
• AAV-based gene therapy has demonstrated success in preclinical models of inherited muscle disorders and shows promise in early clinical trials.

Purpose of the Study:

• To present a standardized protocol for the production and purification of adeno-associated virus (AAV) vectors.
• To provide a versatile methodology applicable to diverse AAV variants for research and therapeutic applications.

Main Methods:

• Development of a generic protocol for AAV vector production.
• Implementation of purification techniques suitable for various engineered AAV variants.
• Characterization of AAV vector transduction efficiency in vivo across different species.

Main Results:

• AAV vectors demonstrate robust and sustained in vivo transduction in various animal models, including rodents, dogs, and non-human primates.
• Engineered AAV variants with modified capsids and genomes have been developed to meet specific research requirements.
• The outlined protocol is broadly applicable to the production and purification of numerous AAV variants.

Conclusions:

• The described AAV production and purification protocol is a valuable resource for researchers studying myogenesis and developing gene therapies.
• This standardized method supports the advancement of AAV-based research and therapeutic strategies for muscle-related conditions.
• The protocol's versatility ensures its applicability across a wide range of AAV variants, facilitating broader research endeavors.